REFERENCES
- Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers YC, Abrams HL, Merrill JP. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175–185.
- Gillenwater JY, Dooley ES, Frohlich ED. Effects of endotoxin on renal function and hemodynamics. Am J Physiol 1963; 205: 293–297.
- Gupta JD, Reed CE. The role of serum lipase in the degradation of salmonella enteritis endotoxin. J Immunol 1968; 101: 308–316.
- Kew MC, Brunt PW, Varma RR, Hourigan KJ, Williams HS, Sherlock S. Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet 1971; 11: 504–510.
- Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ. Endotoxemic acute renal failure in awake rats. Am J Physiol 1986; 250: F1098–F1106.
- Koscar LT, Bertok J, Varteresz V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 1969; 100: 220–223.
- Marshall WJ, McLean AEM. The effect of oral phenobarbitone on hepatic microsomal cytochrome p-450 and demethylation activity in rats fed normal and low protein diets. Biochem Pharmacol 1969; 18: 153–157.
- Mathison JCR, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 123: 2133–2143.
- Nolan JP. The role of endotoxin in liver injury. Gastroenterol 1975; 69: 1346–1356.
- Nolan JP, Camera DS. Endotoxin, sinusoidal cells and liver injury. Popper H, Schaffer F. (eds). Progress in liver diseases. Vol 7, New York: Grune & Stratton, 1982: 361–376.
- Papper S, Belsky JL, Bleifer KH. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features. Ann Intern Med 1959; 51: 759–773.
- Ruiter DJ, Meulen J, Brouwer A, Hummel MJR, Mauw BJ, Ploeg JCM, Wisse E. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 1981; 45: 38–45.
- Shirai M, Nishioka M, Shiga J, Mori W, Fukuda I, Kanegasaki S. Fate of 3H-labeled endotoxin in partial hepatectomised rats. Hepatogastroenterol 1988; 35: 107–110.
- Shirai M, Shiga J, Yoshimura A, Fukuda I, Kanegasaki S, Mori W. The organ of distribution of [3H] Endotoxin following partial hepatectomy. Jap J Exp Med 1988; 58: 219–224.
- Tarao K, SO K, Moroi T, Ikeuchi T, Suyama T, Endo O, Fukushima K. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance. Gastroenterol 1977; 73: 539–542.
- Triger DR, Boyer TD, Levin J. Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut 1978; 19: 935–939.
- Westphal O, Brade H. Bacterial lipopolysaccharides and their lipid A component. Homma JY, Kanegasaki S, Luderitz O, Shiba T, Westphal O. (eds.). Bacterial Endotoxin. Basel: Verlag Chemie, 1984: 11–12.
- Westphal O, Jann K. Bacterial lipopolysaccharides, extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry 1965; 5: 83–91.
- Wilkinson SP. Renal failure. Wilkinson SP. (ed). Hepatorenal disorders. 1st ed. New York: Mercel Dekker Inc., 1982: 1–54.
- Zipser RD, Radvan GH, Kronborg IJ, Duke R, Little TE. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterol 1983; 84: 697–703.
- Solez K. Acute renal failure (Acute tubular necrosis, Infarction, and Cortical Necrosis). Heptinstall RH (ed.). Pathology of the Kidney. 3rd ed. Boston: Little Brown, 1983; 1069–1148.
- Wilkinson SP, Hirst D, Day DW, Williams R. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol 1978; 31: 101–107.